Increasing Age Predicts Poor Cervical Cancer Prognosis with Subsequent Effect on Treatment and Overall Survival

le Quinn, Bridget A., Deng, Xiaoyan, Colton, Adrianne, Bandyopadhyay, Dipankar, Carter, Jori, Fields, Emma C.
Foilsithe in Brachytherapy (2018)

Development of a syngeneic mouse model of epithelial ovarian cancer

le Quinn, Bridget A, Xiao, Fang, Bickel, Laura, Martin, Lainie, Hua, Xiang, Klein-Szanto, Andres, Connolly, Denise C
Foilsithe 2010

Induction of Ovarian Leiomyosarcomas in Mice by Conditional Inactivation of Brca1 and p53

le Quinn, Bridget A., Brake, Tiffany, Hua, Xiang, Baxter-Jones, Kimberly, Litwin, Samuel, Ellenson, Lora Hedrick, Connolly, Denise C.
Foilsithe 2009

Reversing Translational Suppression and Induction of Toxicity in Pancreatic Cancer Cells Using a Chemoprevention Gene Therapy Approach

le Sarkar, Siddik, Quinn, Bridget A., Shen, Xuening, Dent, Paul, Das, Swadesh K., Emdad, Luni, Sarkar, Devanand, Fisher, Paul B.
Foilsithe in Mol Pharmacol (2015)

Pancreatic cancer-specific cell death induced in vivo by cytoplasmic-delivered polyinosine-polycytidylic acid

le Bhoopathi, Praveen, Quinn, Bridget A., Gui, Qin, Shen, Xue-Ning, Grossman, Steven R., Das, Swadesh K., Sarkar, Devanand, Fisher, Paul B., Emdad, Luni
Foilsithe 2014

Mcl-1 is an important therapeutic target for oral squamous cell carcinomas

le Maji, Santanu, Samal, Sabindra K, Pattanaik, Laxmipriya, Panda, Swagatika, Quinn, Bridget A., Das, Swadesh K., Sarkar, Devanand, Pellecchia, Maurizio, Fisher, Paul B., Dash, Rupesh
Foilsithe in Oncotarget (2015)

Pancreatic cancer combination therapy using a BH3 mimetic and a synthetic tetracycline

le Quinn, Bridget A., Dash, Rupesh, Sarkar, Siddik, Azab, Belal, Bhoopathi, Praveen, Das, Swadesh K., Emdad, Luni, Wei, Jun, Pellecchia, Maurizio, Sarkar, Devanand, Fisher, Paul B.
Foilsithe in Cancer Res (2015)

Design and characterization of novel EphA2 agonists for targeted delivery of chemotherapy to cancer cells

le Wu, Bainan, Wang, Si, De, Surya K., Barile, Elisa, Quinn, Bridget A., Zharkikh, Irina, Purves, Angela, Stebbins, John L., Oshima, Robert G., Fisher, Paul B., Pellecchia, Maurizio
Foilsithe in Chem Biol (2015)

Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic

le Sarkar, Siddik, Quinn, Bridget A., Shen, Xue-Ning, Dash, Rupesh, Das, Swadesh K., Emdad, Luni, Klibanov, Alexander L., Wang, Xiang-Yang, Pellecchia, Maurizio, Sarkar, Devanand, Fisher, Paul B.
Foilsithe in Oncotarget (2015)

Targeting the Bcl-2 Family for Cancer Therapy

le Thomas, Shibu, Quinn, Bridget A., Das, Swadesh K., Dash, Rupesh, Emdad, Luni, Dasgupta, Santanu, Wang, Xiang-Yang, Dent, Paul, Reed, John C., Pellecchia, Maurizio, Sarkar, Devanand, Fisher, Paul B.
Foilsithe 2012

Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine

le Quinn, Bridget A., Wang, Si, Barile, Elisa, Das, Swadesh K., Emdad, Luni, Sarkar, Devanand, De, Surya K., Kharagh, Susan Morvaridi, Stebbins, John L., Pandol, Stephen J., Fisher, Paul B., Pellecchia, Maurizio
Foilsithe in Oncotarget (2016)

Enhanced Prostate Cancer Gene Transfer and Therapy Using a Novel Serotype Chimera Cancer Terminator Virus (Ad.5/3-CTV)

le AZAB, BELAL M., DASH, RUPESH, DAS, SWADESH K., BHUTIA, SUJIT K., SARKAR, SIDDIK, SHEN, XUE-NING, QUINN, BRIDGET A., DENT, PAUL, DMITRIEV, IGOR P., WANG, XIANG-YANG, CURIEL, DAVID T., PELLECCHIA, MAURIZIO, REED, JOHN C., SARKAR, DEVANAND, FISHER, PAUL B.
Foilsithe in J Cell Physiol (2014)

Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in...

le Azab, Belal, Dash, Rupesh, Das, Swadesh K., Bhutia, Sujit K., Shen, Xue-Ning, Quinn, Bridget A., Sarkar, Siddik, Wang, Xiang-Yang, Hedvat, Michael, Dmitriev, Igor P., Curiel, David T., Grant, Steven, Dent, Paul, Reed, John C., Pellecchia, Maurizio, Sarkar, Devanand, Fisher, Paul B.
Foilsithe 2012

Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24–mediated toxicity

le Dash, Rupesh, Azab, Belal, Quinn, Bridget A., Shen, Xuening, Wang, Xiang-Yang, Das, Swadesh K., Rahmani, Mohamed, Wei, Jun, Hedvat, Michael, Dent, Paul, Dmitriev, Igor P., Curiel, David T., Grant, Steven, Wu, Bainan, Stebbins, John L., Pellecchia, Maurizio, Reed, John C., Sarkar, Devanand, Fisher, Paul B.
Foilsithe 2011

Targeting Mcl-1 for the therapy of cancer

le Quinn, Bridget A., Dash, Rupesh, Azab, Belal, Sarkar, Siddik, Das, Swadesh K., Kumar, Sachin, Oyesanya, Regina A., Dasgupta, Santanu, Dent, Paul, Grant, Steven, Rahmani, Mohamed, Curiel, David T., Dmitriev, Igor, Hedvat, Michael, Wei, Jun, Wu, Bainan, Stebbins, John L., Reed, John C., Pellecchia, Maurizio, Sarkar, Devanand, Fisher, Paul B.
Foilsithe 2011

mda-7/IL-24: A Unique Member of the IL-10 Gene Family Promoting Cancer-Targeted Toxicity

le Dash, Rupesh, Bhutia, Sujit K., Azab, Belal, Su, Zhao-zhong, Quinn, Bridget A., Kegelmen, Timothy P., Das, Swadesh K., Kim, Keetae, Lee, Seok-Geun, Park, Margaret A., Yacoub, Adly, Rahmani, Mohammed, Emdad, Luni, Dmitriev, Igor P., Wang, Xiang-Yang, Sarkar, Devanand, Grant, Steven, Dent, Paul, Curiel, David T., Fisher, Paul B.
Foilsithe 2010

Selected Approaches for Rational Drug Design and High Throughput Screening to Identify Anti-Cancer Molecules

le Hedvat, Michael, Emdad, Luni, Das, Swadesh K., Kim, Keetae, Dasgupta, Santanu, Thomas, Shibu, Hu, Bin, Zhu, Shan, Dash, Rupesh, Quinn, Bridget A., Oyesanya, Regina A., Kegelman, Timothy P., Sokhi, Upneet K., Sarkar, Siddik, Erdogan, Eda, Menezes, Mitchell E., Bhoopathi, Praveen, Wang, Xiang-Yang, Pomper, Martin G., Wei, Jun, Wu, Bainan, Stebbins, John L., Diaz, Paul W., Reed, John C., Pellecchia, Maurizio, Sarkar, Devanand, Fisher, Paul B.
Foilsithe 2012